PreprintAll rights reservedmedRxiv
Estrogen interactions with breast cancer risk variants in regulatory DNA
- 1Stanford University
Related
- Repeat element-anchored enhancer-promoter interactions (REEPIs) shape the regulatory landscape of hormone-resistant breast cancer
- Selective estrogen receptor degraders and their effect on the breast cancer immune microenvironment
- Tamoxifen and Doxorubicin Synergistically Target Estrogen Receptor beta-Mutant p53-p73 Axis, a Therapeutically Actionable Vulnerability in Triple Negative Breast Cancer
- Pharmacological chromatin remodeling enhances response to estrogen therapy in ER + breast cancer
- Estradiol Modulates Cytotoxic Responses to Topoisomerase II Targeting Agents in Estrogen Receptor Positive Breast Cancer Cells
BibTeX
@misc{elfaki2026estrogen,
title = {{Estrogen interactions with breast cancer risk variants in regulatory DNA}},
author = {I. M. Elfaki and L. Kellman and R. Meyers and L. Ducoli and M. Fu and K. Obbad and S. Mondal and X. Yang and D. F. Porter and D. Reynolds and S. Srinivasan and T. Nakase and M. Ota and T. Fabo and J. Meyers and L. Yang and N. Sinnot-Armstrong and K. Westerman and L. Kachuri and P. Khavari},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.09.26362309},
url = {https://www.medrxiv.org/content/10.64898/2026.09.09.26362309v1},
}
RIS
TY - UNPB
TI - Estrogen interactions with breast cancer risk variants in regulatory DNA
AU - I. M. Elfaki
AU - L. Kellman
AU - R. Meyers
AU - L. Ducoli
AU - M. Fu
AU - K. Obbad
AU - S. Mondal
AU - X. Yang
AU - D. F. Porter
AU - D. Reynolds
AU - S. Srinivasan
AU - T. Nakase
AU - M. Ota
AU - T. Fabo
AU - J. Meyers
AU - L. Yang
AU - N. Sinnot-Armstrong
AU - K. Westerman
AU - L. Kachuri
AU - P. Khavari
PY - 2026
DA - 2026/09/09
PB - medRxiv
DO - 10.64898/2026.09.09.26362309
UR - https://www.medrxiv.org/content/10.64898/2026.09.09.26362309v1
ER -